---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-026924"
form_type: "8-K"
ticker: "PBYI"
cik: "0001401667"
company_name: "PUMA BIOTECHNOLOGY, INC."
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-21T22:37:53.799756+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Puma Biotechnology settles defamation lawsuit for $16M; payments due in 2023 and 2024

## Summary
- Settlement with Dr. Fredric Eshelman for $16M resolves defamation lawsuit; no admission of liability.
- First payment of $8M due by Jan 31, 2023; second payment of $8M due by Nov 1, 2024.
- Original jury award of $22.4M vacated on appeal; settlement avoids new trial on damages.
- Lawsuit dismissed with prejudice; each party bears its own costs and fees.

## SEC filing metadata
- accession: 0001437749-22-026924
- form_type: 8-K
- ticker: PBYI
- cik: 0001401667
- company_name: PUMA BIOTECHNOLOGY, INC.
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401667/000143774922026924/0001437749-22-026924-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401667/000143774922026924/pbyi20221109_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-026924
- JSON: https://secwatch.observer/filing/0001437749-22-026924.json
- Plain text: https://secwatch.observer/filing/0001437749-22-026924.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.